In the course of our screening for inhibitors of abl oncogene function, a culture nitrate of Streptomyces aculeolatus. induced normal flat morphology in v-abl-expressing NIH3T3 cells. The active substance was isolated through ethyl acetate extraction, silica gel column chromatography, and reverse-phase HPLC. Mass and NMRspectroscopy including HMBCrevealed that it had a novel naphthoquinone structure with a monoterpene, and we namedit "naphthablin". Naphthablin inhibited Abl-induced morphological transformation in v-ablts-NIH3T3 cells at around 30 /zg/ml, and specifically inhibited RNAsynthesis.
In human chronic myelogenous leukemia (CML), the cellular oncogene abl is activated by chromosomal translocation to give bcr-abl1}. The product of bcr-abl or viral abl has higher tyrosine kinase activity than that of unactivated cellular abl2). A tyrosine kinase inhibitor, herbimycin, was shown to induce erythroid differentiation in human CMLK562 cells, and also showed antitumor activity against abl-expressing tumors in mice3).
Recently, we isolated aristeromycin from Actinomycetes as an inhibitor of v-abl functions40. Aristeromycin induced normal morphology in v-ablts-NIH3T3 cells and erythroid differentiation in K562 cells. It did not inhibit cellular tyrosine phosphorylation, but inhibited methylation reactions such as the conversion of phosphatidylethanolamine to phosphatidylcholine in K562 cells. As anti-Abl compoundsmaybecomeeffective chemotherapeutic agents for use against CML,we have been searching among microbial metabolites for inhibitors of abl function. In the course of our screening for such inhibitors, we have isolated a novel naphthoquinone compound from Streptomyces aculeolatus, which inhibitor is described herein.
Materials and Methods
Cell Culture v-ablts-NIH3T3 cells5) were kindly supplied by Dr. J. Wang, UCSD, San Diego. The cells were cultured in T.d. x250mm) with 90% MeOHcontaining 0.1% trifluoroacetic acid to give 1 1 mg ofa pure orange material.
Results
In the course of our screening for abl oncogene function inhibitors, we found that the culture filtrate of strain MK15-42F22 induced normal flat morphology in v-ablts-NIH3T3 cells at the permissive temperature. The morphology of the producing strain is shown in Fig. 1 . Taxonomic studies indicated that the producing strain belongs to Streptomyces aculeolatus6).
Production of the anti-Abl compounds remained at the same level from 5 to 10 days of cultivation. Therefore, we took the broth on day 5. The active principle was extracted with ethyl acetate, and purified as described in Materials and Methods. The structure of the active compoundwas elucidated by analysis of mainly mass and two-dimensional NMR spectra. Since the structure is novel, as shown in Fig. 2 we named the compound "naphthablin". Physicochemical properties of naphthablin are listed in Table 1 , and the 13C and XHNMRdata appear in Tables 2 and  3 , respectively. The core structure of naphthablin, having naphthoquinone and a monoterpene, is related to those structures of naphterpin7) and naphthgeranine A8).
Amongthem, naphthablin is the most complicated, and it has a substituted propenyl group and an isobutyrate at the 9 and 3 positions, respectively. Naphthablin inhibited Abl-induced morphological transformation in v-ablts-NIH3T3 cells at concentrations of 20~40 /ig/ml. Morphological transformation could be induced in 24 hours by the temperature shift from 39°C to 33°C in v-ablts-NIH3T3 cells, as shown in Figs. 3A and 3C. Addition of 30//g/ml of naphthablin inhibited this transformation, and maintained the flat morphology (Fig. 3B) . The effect of naphthablin on the growth of cultured cells is shown in 
